The Capping Prescription Costs Act of 2025 (H.R. 2553) would cap annual out-of-pocket prescription drug costs at $2,000 for individuals and $4,000 for families beginning in 2026.
Cap annual out-of-pocket prescription drug costs at $2,000 for individuals and $4,000 for families beginning in 2026.
Occurrences
H.R.2553 - Capping Prescription Costs Act of 2025 ... To limit cost-sharing for prescription drugs, and for other purposes.
Evidence
In 2026, Extra Help for Medicare drug coverage says that once total drug costs reach $2,100, the beneficiary pays $0 for each covered drug.
Medicare drug coverage helps pay for brand-name and generic drugs and is offered to everyone with Medicare by private insurance companies.
Assessments
The federal government did enact a narrower prescription-drug out-of-pocket cap that Steven Horsford can claim some credit for. Medicare Part D enrollees got a $2,000 annual out-of-pocket cap starting January 1, 2025, through the Inflation Reduction Act, and Horsford voted for that bill on August 12, 2022 while serving in the House and on Ways and Means. But the enacted policy does not fully match the promise: in 2026 the Medicare Part D threshold is indexed to $2,100, not $2,000; it applies to covered Part D drugs for Medicare beneficiaries rather than all individuals; and there is no corresponding broad $4,000 family cap. Because Horsford materially advanced a related but narrower policy during his term, this is partial rather than full delivery.